Benchmark has raised the price target for Cinemark Holdings (NYSE: NYSE:CNK) to $32 from $25, while maintaining a Buy rating on the stock.
The adjustment comes as the firm revises its fiscal third-quarter 2024 revenue estimates following a stronger-than-anticipated performance at the domestic box office, which has also positively influenced operating leverage and profitability.
The upward revision is based on the box office remaining relatively stable with a minimal 1% decline in attendance and a 1.5% increase in average ticket price (ATP).
The outlook is a significant improvement from the initial forecast, which predicted an 8% decrease in box office revenue due to an expected 10% fall in attendance.
The new estimates suggest a more resilient industry scenario than previously anticipated.
Benchmark also notes that Cinemark has benefited from high demand for concessions and merchandise during the quarter, which should contribute to revenue growth and improved margins.
These factors combined have led to an increase in the firm's adjusted EBITDA (AEBITDA) expectations for the company.
While the domestic market shows promising trends, Benchmark remains cautious about growth in Latin America. The region saw robust demand for family films in July, but other titles such as "Twisters" and "Beetlejuice Beetlejuice" may have underperformed. Additionally, challenges in Brazil, including restrictive ratings for films such as "Deadpool" and "Wolverine," could pose hurdles for Cinemark's performance in the area.
In other recent news, Cinemark Holdings, Inc. has completed the early redemption of its 5.875% Senior Notes due 2026, effectively discharging the debt almost a year before its maturity date.
This move, part of Cinemark's broader debt management strategy, covered the entire outstanding principal amount of $59,715,000.
In the wake of this development, B.Riley shifted its stance on Cinemark from a Buy rating to Neutral, citing the stock price's proximity to the firm's price target of $31.00.
This change was not driven by a negative view of the company's fundamentals or the domestic box office's anticipated recovery.
Simultaneously, Jefferies maintained a Buy rating on Cinemark, raising the price target to $30.00. Both B.Riley and Jefferies acknowledged Cinemark's strong second-quarter performance, which exceeded expectations with robust worldwide revenue of $734.2 million, primarily attributed to significant growth in admissions revenue and concession sales.
Furthermore, Cinemark reported a record-breaking September weekend at the domestic box office, largely due to the success of the "Beetlejuice" sequel.
The company's focus on customer service and advanced sight and sound technology contributed to this achievement. Lastly, Cinemark is considering returning excess capital to shareholders and plans to repay $460 million of convertible notes in August 2025.
InvestingPro Insights
Cinemark Holdings' (NYSE:CNK) recent performance aligns with Benchmark's optimistic outlook. According to InvestingPro data, the company's stock has shown remarkable strength, with a 54.92% price total return over the past six months and a substantial 97.59% year-to-date return. This upward trajectory is reflected in an InvestingPro Tip noting that Cinemark is trading near its 52-week high, currently at 95.77% of that peak.
The company's financial health appears solid, with an InvestingPro Tip highlighting that liquid assets exceed short-term obligations. This liquidity position could provide Cinemark with the flexibility to capitalize on the improving box office trends noted in Benchmark's analysis. Additionally, with a P/E ratio of 23.76, investors are showing confidence in the company's earnings potential, which corresponds with another InvestingPro Tip indicating that analysts predict profitability for the current year.
For readers seeking a deeper understanding of Cinemark's financial position and market performance, InvestingPro offers 7 additional tips, providing a comprehensive view of the company's prospects in the evolving entertainment landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.